Pancreatic Cancer Research

ResearcherChampalimaud FoundationActive in the last 2 years

Celso Matos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7383-6309; OpenAlex author ID A5057794986. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 4

  1. Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis. Last author DOI 10.1007/s00330-023-10381-0↗
  2. Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management. Last author DOI 10.1016/j.ejro.2024.100553↗
  3. Assessment of response to chemotherapy in pancreatic ductal adenocarcinoma: Comparison between diffusion-weighted MR quantitative parameters and RECIST. Co-author DOI 10.1016/j.ejrad.2018.04.024↗
  4. Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy. First author DOI 10.1148/radiol.2018171670↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carlos Bilreiro · 2 shared papers, 2024 · strength 0.59
  2. Christophe Cassinotto · 1 shared paper, 2018 · strength 0.14
  3. Marc Zins · 1 shared paper, 2018 · strength 0.14
  4. Raphaël Maréchal · 1 shared paper, 2018 · strength 0.08
  5. Jean‐Luc Van Laethem · 1 shared paper, 2018 · strength 0.08
  6. Maria Antonietta Bali · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.